IBIO logo

IBIOiBio Inc

$1.83
$0.08
(4.54%)
Today
Closed $1.84
$0.0069
(0.38%)
After Hours
Updated: 07:32 PM EDT
Mkt Cap$87.43M
Vol725,421.00
News
all
press releases
iBio, Inc. (NASDAQ:IBIO) Given Consensus Recommendation of "Buy" by Analysts
Shares of iBio, Inc. (NASDAQ:IBIO - Get Free Report) have been given an average recommendation of "Buy" by the six brokerages that are covering the firm, MarketBeat reports. One research analyst has...
MarketBeat
News Placeholder
More News
News Placeholder
iBio (IBIO) Projected to Post Quarterly Earnings on Friday
iBio (NASDAQ:IBIO) will be releasing its Q3 2026 earnings before the market opens on Friday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-1-ibio-inc-stock-3...
MarketBeat
News Placeholder
iBio (NASDAQ:IBIO) Earns Buy Rating from Chardan Capital
Chardan Capital restated a "buy" rating and issued a $5.00 target price on shares of iBio in a report on Thursday...
MarketBeat
News Placeholder
iBio Details Generative AI Antigen Platform to Speed GPCR Antibody Discovery and Close Trust Gap
iBio (NASDAQ:IBIO) is seeking to narrow what it views as a growing trust gap between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market...
MarketBeat
News Placeholder
IBIO Stock Is Soaring Today After iBio's Muscle-Preserving Drug Receives Approval For Human Trial In Australia
iBio stated that IBIO-600 has been approved by Australia’s Therapeutic Goods Administration to initiate a Phase 1 study in overweight and obese adult participants.
Stocktwits
News Placeholder
iBio, Inc. (NASDAQ:IBIO) Given Average Recommendation of "Buy" by Analysts
iBio, Inc. (NASDAQ:IBIO - Get Free Report) has received a consensus recommendation of "Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. One research...
MarketBeat
News Placeholder
iBio (NASDAQ:IBIO) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded iBio from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat
News Placeholder
Insider Buying: iBio (NASDAQ:IBIO) CFO Buys 24,835 Shares of Stock
iBio, Inc. (NASDAQ:IBIO - Get Free Report) CFO Felipe Duran bought 24,835 shares of the stock in a transaction dated Thursday, March 19th. The stock was purchased at an average price of $2.02 per...
MarketBeat
News Placeholder
iBio (NASDAQ:IBIO) CFO Felipe Duran Acquires 24,835 Shares
iBio, Inc. (NASDAQ:IBIO - Get Free Report) CFO Felipe Duran bought 24,835 shares of the company's stock in a transaction dated Thursday, March 19th. The stock was purchased at an average price of...
MarketBeat
News Placeholder
Martin Brenner Purchases 12,336 Shares of iBio (NASDAQ:IBIO) Stock
iBio, Inc. (NASDAQ:IBIO - Get Free Report) insider Martin Brenner purchased 12,336 shares of the stock in a transaction dated Thursday, March 19th. The stock was purchased at an average cost of $2.02...
MarketBeat
<
1
2
...
>